A Drug-Drug Interaction Study of Digoxin and PA21

• Status: Completed
• Trial end date: 2012-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if Digoxin is affected by PA21.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Vifor Inc.; Vifor Pharma
• Treatments: Digoxin

Criteria

Inclusion Criteria:

• Healthy volunteers

• Written informed consent

Exclusion Criteria:

• No significant medical conditions

• Pregnancy